Demonstrates enhanced activation of dendritic cells in response to a homogenous nanovaccine, indicating improved immune responses.
Introduction Previously, we employed a heterogeneously-sized PLGA (poly D, L-lactide-co-glycolide) encapsulating chlamydial major outer membrane protein (MOMP) nanovaccine (CnV), which induced Th1 immune responses in bone marrow-derived dendritic cells (BMDCs). Herein, we employed a microfluidics-assisted fabrication technique to obtain homogenously-sized CnV-H to assess the effects of size and homogeneity on innate immune responses. We hypothesized that due to homogeneity, CnV-H will bolster Th1 immune responses in BMDCs as compared to CnV. Methods The characterization data revealed that CnV-H had an average size of 166 nm, a surface charge of -2 mV and exhibited homogeneity as evidenced by a low polydispersity index (PDI > 0.06) and as confirmed by scanning electron microscopy. Contrastingly, CnV had an average size of 180 nm, a surface charge of -12 mV and a PDI (> 0.1), indicating heterogeneity. To assess in-nate immune responses, BMDCs were stimulated for 24 hours with CnV-H and or CnV (0.1, 1, and 5 µg/mL of encapsulated-rMOMP). Supernatants were collected for cytokine-specific ELISAs, and cells were processed for gene-expression analysis using TaqMan qPCR or were stained with fluorochrome-conjugated antibodies specific for co-stimulatory and antigen-presentation molecules for flow cytometry assessment. Results The data showed that higher concentrations (1 and 5 µg/ml) led to activation of the caveolin en-docytosis pathway, enhanced expression of pathogen pattern recognition receptors (TLR-2), co-stimulatory molecules (CD40, CD80, CD86), antigen-presentation molecules (MHC-II), and significantly increased Th1-cytokines (IL-6, IL-12p40) production, particularly TNF-α, compared to the CnV-stimulated BMDCs. The negative control CnV or CnV-H did not induce any cytokine production. Conclusion In summary, homogeneously-sized CnV-H is more efficient at activating dendritic cells, potentially for robust antigen-presentation, likely due to the uniform activation of the caveolin endocytosis pathway. Funding Source This research was supported by the National Science Foundation (NSF)-HBCU-UP (HRD-1911660) and the NSF-EiR (2200529) grants to Dr. Vida A. Dennis at Alabama State University.
No takes yet. Share an insight, caveat, or question.
Sahu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: